References
1. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002.
2. Bao W, Yeung E, Tobias DK, Hu FB, Vaag AA, Chavarro JE, et al. Long-term risk of type 2 diabetes mellitus in relation to BMI and weight change among women with a history of gestational diabetes mellitus: a prospective cohort study. Diabetologia. 2015;58(6):1212-9.
3. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-86.
4. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339-48.
5. Farrar D, Simmonds M, Griffin S, Duarte A, Lawlor DA, Sculpher M, et al. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation. Health Technol Assess. 2016;20(86):1-348.
6. Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012;35(3):526-8.
7. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med. 2004;21(2):103-13.
8. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period NICE Guideline 3. Methods, Evidence and Recommendations 2015.
9. Rebel A, Rice MA, Fahy BG. Accuracy of point-of-care glucose measurements. J Diabetes Sci Technol. 2012;6(2):396-411.
10. McGrath RT, Donnelly VC, Glastras SJ, Preda VA, Sheriff N, Ward P, et al. Evaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes Clinic. Diabetes Technol Ther. 2016;18(2):68-74.
11. Kumar V, Indukuri D, Bhat N. Analysis of five glucometers available in India. International Journal of Diabetes in Developing Countries. 2015;35(3):189-96.
12. DuBois JA, Slingerland RJ, Fokkert M, Roman A, Tran NK, Clarke W, et al. Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings. Crit Care Med. 2017;45(4):567-74.
13. Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Pape-Medvidović E, Ljubić S. Validation of Point-of-Care Glucose Testing for Diagnosis of Type 2 Diabetes. Int J Endocrinol. 2013;2013:206309.
14. Corporation NB. The StatStrip®
Glucose and ß-Ketone Hospital Meter Instructions for Use Manual. 2020.
15. T S. Capillary Blood Glucose Screening (Accu-Chek Advantage) for Gestational Diabetes. J Med Assoc Thai. 2009.
16. Stavrianos C, Anastasiou E. Oral Glucose Tolerance Test Evaluation With Forearm and Fingertip Glucose Measurements in Pregnant Women. Diabetes Care. 2004;27(2):627-8.
17. Boriboonhirunsarn D, Robkhonburi A, Asad-dehghan M. Accuracy of capillary blood glucose for 50-g glucose challenge test for gestational diabetes screening. Diabetology International. 2022;13(3):561-5.
18. Bruns DE, Knowler WC. Stabilization of glucose in blood samples: why it matters. Clin Chem. 2009;55(5):850-2.
19. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57(6):e1-e47.
20. Daly N, Carroll C, Flynn I, Harley R, Maguire P, Turner M. Evaluation of point-of-care maternal glucose measurements for the diagnosis of gestational diabetes mellitus. BJOG: An International Journal of Obstetrics & Gynaecology. 2017;124(11):1746-52.
21. van den Berg S, Thelen M, Boonen K. Inventarisation of the (pre) analytical aspects of the glucose determination in Dutch laboratories: time for harmonization. Ned Tijdschr Klin Chem Labgeneesk. 2015;40(1):69.
22. Lippi G, Montagnana M, Giavarina D. National survey on the pre-analytical variability in a representative cohort of Italian laboratories. Clin Chem Lab Med. 2006;44(12):1491-4.
23. Bhavadharini B, Mahalakshmi MM, Maheswari K, Kalaiyarasi G, Anjana RM, Deepa M, et al. Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings. Acta Diabetol. 2016;53(1):91-7.
24. García-Claver A, Ramos-Corral R, Laviña-Fañanás C, Solans-Blecua I, Puzo-Foncillas J. Capillary glucose concentration during oral glucose tolerance test for the diagnosis of gestational diabetes. International Journal of Gynecology & Obstetrics. 2020;150(2):234-40.
25. Balaji V, Madhuri BS, Paneerselvam A, Arthi T, Seshiah V. Comparison of venous plasma glucose and capillary whole blood glucose in the diagnosis of gestational diabetes mellitus: a community-based study. Diabetes Technol Ther. 2012;14(2):131-4.
26. Balaji V, Balaji MS, Paneerselvam A, Thiyagarajah A, Seshiah V. Point of care for gestational diabetes mellitus–a community-based study. J Indian Med Assoc. 2012;110(5):314-6.
27. Hossain N, Shah T, Rajar S, Sehtoo A, Riaz M, Fawwad A, et al. Comparison of venous plasma glucose and capillary whole blood glucose in diagnosis of gestational diabetes: Study from Karachi, Pakistan. Clinical Epidemiology and Global Health. 2017;5(4):185-9.
28. Afzal NI, I. Mahmood, A. Nabila, S. Fehmida. Accuracy of Fasting Capillary Blood Glucose by Glucometer for Screening of Gestational Diabetes Mellitus: Simplicity is the Key. JOURNAL OF THE SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF PAKISTAN. 2021;11(Online: 2307-7115):82-6.
29. Jadhav DS, and Uma N. Wankhede. Comparative study of capillary blood glucose estimation by glucometer and venous plasma glucose estimation in women undergoing the one step DIPSI test (diabetes in pregnancy study group India) for screening and diagnosis of gestational diabetes mellitus. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2017;6(4):1488+.
30. O’Malley EG, Reynolds CME, O’Kelly R, Killalea A, Sheehan SR, Turner MJ. A Prospective Evaluation of Point-of-Care Measurements of Maternal Glucose for the Diagnosis of Gestational Diabetes Mellitus. Clin Chem. 2020;66(2):316-23.
31. Adam S, Rheeder P. Evaluating the utility of a point-of-care glucometer for the diagnosis of gestational diabetes. Int J Gynaecol Obstet. 2018;141(1):91-6.
32. van den Berg SA, de Groot MJ, Salden LP, Draad PJ, Dijkstra IM, Lunshof S, et al. Pregnancy diabetes: A comparison of diagnostic protocols based on point-of-care, routine and optimized laboratory conditions. Sci Rep. 2015;5:16302.
33. GALLARDO H, LOMELIN-GASCON J, MARTINEZ LA, MONTOYA A, REYES-MUÑOZ E, TAPIA-CONYER RC. 1358-P: Point of Care OGTT for the Screening of Gestational Diabetes: A Feasible Proposal for Low-Resource Settings. Diabetes. 2020;69(Supplement_1).
34. Kristensen K, Wangel A-M, Katsarou A, Shaat N, Simmons D, Fadl H, et al. Diagnosis of Gestational Diabetes Mellitus with Point-of-Care Methods for Glucose versus Hospital Laboratory Method Using Isotope Dilution Gas Chromatography-Mass Spectrometry as Reference. Journal of Diabetes Research. 2020;2020:7937403.
35. Landberg E, Nevander S, Hadi M, Blomberg M, Norling A, Ekman B, et al. Evaluation of venous plasma glucose measured by point-of-care testing (Accu-Chek Inform II) and a hospital laboratory hexokinase method (Cobas c701) in oral glucose tolerance testing during pregnancy – a challenge in diagnostic accuracy. Scandinavian Journal of Clinical and Laboratory Investigation. 2021;81(8):607-14.
36. SAbo-Elkheir EMM DA, Hazzaa SME, El-Gharib MN. The Accuracy of Capillary Whole Blood Glucose Versus Venous Plasma Glucose in the Diagnosis of Gestaonal Diabetes Mellitus in Egypan Women. J Womens Health Reprod. 2020;Med Vol. 4 No.3:4.
Table 1: Number (n) Percentage % of pregnant women meeting GDM diagnostic thresholds (fasting ≥ 5.6 mmol/L, 2-hour ≥ 7.8 mmol/L) with each method, sensitivity and specificity, FP FN rates, PPV and NPV for POC-StatStrip®.